Phase II proof-of-concept study of atiprimod in patients with advanced low- to intermediate-grade neuroendocrine carcinoma

M. W. Sung, L. Kvols, G. Jacob, C. Talluto, J. C. Torres, A. Parta, E. Rodriguez, R. Shepard

Source record

Source: Crossref

Published: May 20, 2008

DOI: 10.1200/jco.2008.26.15_suppl.4611

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.